about
Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune ResponseCurrent status of immunotherapySingle-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer.Hurdles to the Development of Effective HBV Immunotherapies and HCV VaccinesChemotherapy and radiation therapy elicits tumor specific T cell responses in a breast cancer patientImpaired Subset Progression and Polyfunctionality of T Cells in Mice Exposed to Methamphetamine during Chronic LCMV Infection.Characterization of age-associated exhausted CD8⁺ T cells defined by increased expression of Tim-3 and PD-1.Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seqDivide, Conquer, and Sense: CD8+CD28- T Cells in Perspective.Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinomaThe immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma.CD8+ T Cells in Chronic Periodontitis: Roles and Rules.OMIP-036: Co-inhibitory receptor (immune checkpoint) expression analysis in human T cell subsets.Immune Exhaustion and Transplantation.CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancerImplication of protein tyrosine phosphatase SHP-1 in cancer-related signaling pathways.HTLV-1 Infection and Neuropathogenesis in the Context of Rag1-/-γc-/- (RAG1-Hu) and BLT Mice.CD8+ T Cells That Coexpress RORγt and T-bet Are Functionally Impaired and Expand in Patients with Distal Bile Duct Cancer.A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells.Sepsis in PD-1 light.Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes.Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer.Atorvastatin downregulates co-inhibitory receptor expression by targeting Ras-activated mTOR signalling.Analysis of PD-1 expression in the monocyte subsets from non-septic and septic preterm neonates.Modeling tumor immunity of mouse glioblastoma by exhausted CD8+ T cells.CAR-T cells and combination therapies: What's next in the immunotherapy revolution?CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells.Checkpoint Inhibitors: Applications for Autoimmunity.Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance.Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung Cancer.PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody.Towards a better cancer precision medicine: systems biology meets immunotherapy.Receptors That Inhibit Macrophage Activation: Mechanisms and Signals of Regulation and Tolerance.T Cell Calcium Signaling Regulation by the Co-Receptor CD5.B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients.Not All Immune Checkpoints Are Created EqualInfluence of T Cell Coinhibitory Molecules on CD8 Recall ResponsesMUC1 Mucin: A Putative Regulatory (Checkpoint) Molecule of T Cells
P2860
Q26744527-91740881-89F3-453E-B9FD-2EF1DAF0A85EQ26773314-8645657F-B387-4D3E-8B88-2BD544FAEC2BQ33654352-0AF61B22-E98F-4A89-8CEE-0DB2C11339ECQ33840260-B5C23B9D-8DE2-4717-A2AF-7611456BFDCAQ36093045-0E9C1D1A-9801-40E9-88C5-720E6D8581FCQ36168052-D7B96CA0-E79D-432D-A618-680F27852439Q36665452-05E8BDE6-B357-4B32-91B9-8AF1A5143F12Q37094024-E84B7D78-AC18-4DBA-828F-E34B67CD7AA6Q37550716-04D200A5-1FD7-4D27-A188-4FC31F8F8AA7Q37617052-79B2376B-7D41-46D3-B4B0-0CD05B19D481Q37622429-0CD9F03F-FD23-44F1-8888-85B642FBC3FAQ37653833-17116DE5-C25B-4E3B-B600-249C159D7F49Q37732151-350636B0-B1E1-4EE8-AD30-6624E0505312Q38686551-A0EB0DEF-69C9-42DA-BAAC-22176B8D8017Q38751056-DB851D04-2F0A-4FEC-A03A-0CA66298F8DFQ38778743-C18AE8CC-8C52-46C9-9C8E-68113DE21B01Q39024287-DC7E89E2-FF1D-4BE4-B505-C2CD99462C66Q40385196-F9C16B58-64DE-4FC4-8FE9-080AB806E16EQ40545886-C39C10E2-3531-4786-9729-088C0C08BDD5Q40625575-679169E7-2A16-4DB4-8CDD-5599E5D7E98DQ41031697-2E27DC2E-EFAD-4505-8615-A15320340667Q42369857-BDF71D5B-6C21-4F8A-8CAB-F2F7835FD8CBQ47125276-08324BC8-6602-4775-897D-3580B75DEF22Q47139345-D6965AA6-54E9-41C3-B59C-256EC67E2A8FQ47215596-C08FDFF0-9A3B-4B0D-939E-2542E28AD696Q47285613-961E2464-DDE0-41A6-B933-2FE0693BEA1EQ48331916-08963E6F-A1BD-42C5-8317-C05446ABA561Q49689975-0FA5F097-561B-4164-8274-B3647A0FBD0EQ49865078-69E522A7-AAFA-47F2-9AA5-5561D2F1B499Q50326769-4CE0B37A-06C2-448E-9416-9DA1D80B86D7Q50445792-546E17D7-89E7-4771-920D-72841802C78FQ54967177-0CD34ED4-4D8B-42A6-94B7-CB01300AA768Q54995947-092A5FAC-6488-48C8-BC53-CAFE108FF0C6Q55000833-E27C1A6F-DF9B-4F63-AB6E-801994A58F17Q55110736-1C4A320B-F31B-421E-9087-FBA85E7B438DQ56889626-AF29122A-B553-4251-8DB7-2A46860B712BQ56890230-2B8B2BB9-955E-42B3-8A0F-6ABD4CDB71A4Q58580439-B73043C8-00CA-405A-BA88-49D42FEEC635
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Inhibitory Receptors Beyond T Cell Exhaustion.
@ast
Inhibitory Receptors Beyond T Cell Exhaustion.
@en
type
label
Inhibitory Receptors Beyond T Cell Exhaustion.
@ast
Inhibitory Receptors Beyond T Cell Exhaustion.
@en
prefLabel
Inhibitory Receptors Beyond T Cell Exhaustion.
@ast
Inhibitory Receptors Beyond T Cell Exhaustion.
@en
P2860
P50
P356
P1476
Inhibitory Receptors Beyond T Cell Exhaustion
@en
P2093
Daniel E Speiser
P2860
P356
10.3389/FIMMU.2015.00310
P577
2015-06-26T00:00:00Z